Citeline, Sitetrove: 治験責任医師と治験施設情報のデータベース, Trialtrove: 医療用医薬...
Even one misstep in your clinical trials strategy or execution can cost your company millions. Save time and cost with the trusted source for global investigator and site intelligence and global pharmaceutical clinical trial intelligence by subscribing to Sitetrove and Trialtrove.
To increase flexibility and efficiency in drug development, master protocols have emerged as an innovative clinical trial design, including basket and umbrella trials. Learn more about how these approaches are being used within oncology research through an overview of the clinical landscape, trial outcomes and trends.
Depression affects approximately 1 in 6 Americans, with 10 – 30% of depression patients becoming treatment-resistant. Find out what the pipeline looks like for depression and what the emerging strategies in this area are. This data-packed whitepaper from Informa Pharma Intelligence can now be downloaded – free.
Datamonitor Healthcare: 医療用医薬品の市場調査レポート
This web event has now ended. You will be able to watch all sessions on demand soon. Register your interest now to receive an update when all sessions are available to view.
KNect365 Life Sciences recently conducted a survey into the clinical trial industry at its most interesting point to date, as organisations are implementing new technologies and trends such as AI, virtual trials and wearables. The final report, based on 214 responses, reveals unique insights into what current benefits and challenges companies are facing in the processes of applying these new approaches to therapeutic development. Citeline introduces the report, exploring what some of the key takeaways mean for the industry.
Get a deeper understanding of breast cancer clinical trials initiated since 2014 and what the trends have meant for strategies in this area, with this free whitepaper from Citeline.
Get the big picture trends and key takeaways with Citeline’s infographic, 2019 Completed Trials: The Beat Goes on for Industry Sponsored Trial Activity. Using pivotal data from Sitetrove, Trialtrove and Pharmaprojects, our graphic analysis covers the major industry clinical developments as only Citeline can.
Citeline’s completed clinical trial landscape provides a more granular view of how companies are progressing their pipelines and the disease strategies they are pursuing, compared to static pipeline snapshots.
The clinical trial landscape continues to evolve as scientific breakthroughs and technological innovations emerge. Examine the state of Phase I–III clinical trials initiated in 2019 when you download the Annual Clinical Trials Roundup from Citeline’s Trialtrove, your trusted source for global clinical trials intelligence.
Join our panel of experts as they discuss the impact of COVID-19 on clinical trials, the new normal and future pathways to get ahead. Get the latest insights and status on recent clinical trials, the emergence of virtual trials, and what you need to know for success.
Gain Clarity of Sight into What Comes Next with Citeline According to Informa’s Pharmaprojects, less than 3% of all rare congenital and genetic diseases have an approved therapy. Opportunities abound if you know the risks. Make better strategic and planning decisions with Intelligence services that give you a clear line of sight, helping you maximize clinical and commercial opportunities, navigate uncertainties, and ensure more successful outcomes.
Listen to our podcast “The Future of Clinical Trials From the Investigator Perspective” from earlier this year and register for our upcoming webinar to learn new developments
Ian specializes in
+33 year(s) experience
Susan specializes in
+24 year(s) experience
Andrew specializes in
+20 year(s) experience